• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Colonoscopy could be costeffectiveonly in middle age

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 30 No 12
Volume 30
Issue 12

New evidence suggests conducting screening colonoscopies for people in their mid- 50s saves money. But other evidence indicates there may be an upper age limit for the benefits of such screening.

New evidence suggests conducting screening colonoscopies for people in their mid- 50s saves money. But other evidence indicates there may be an upper age limit for the benefits of such screening.

Dr. Jianjun Li and colleagues from Maimonides Medical Center in Brooklyn conducted free screening colonoscopies for 248 consecutive patients with a mean age of 55. Follow-up detected colon cancer and large polyps in about one in 10.The screening program cost $390,000. Had these patients not been screened, their delayed treatment would have cost Medicare nearly $1.3 million. Li released results at the 2008 American College of Gastroenterology meeting.

On the other hand, the U.S. Preventive Services Task Force, an independent panel of the Department of Health and Human Services, recommended that screening cease when men reach age 75, when the possible harm from screening outweighs its benefits. The task force report was published in the Annals of Internal Medicine (2008;149[3]: 185-191).

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.